# Rafael Holdings Inc. (RFL)

Source: https://www.quantisnow.com/company/RFL
Generated: 2026-11-12T23:28:57.114Z

- Ticker: RFL
- Exchange: NYSE
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2018
- SEC CIK: 0001713863
- Website: rafaelholdings.com

## About

Rafael Holdings, Inc. owns commercial real estate assets and interests in pre-clinical and clinical stage pharmaceutical companies. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.

## Latest RFL news and filings

- 2026-11-09 21:30 UTC [SEC Form 8-K] [Rafael Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/rafael-holdings-inc-filed-sec-form-8-k-regulation-fd-disclosure-6781734)
- 2026-11-03 16:14 UTC [Conference Announcement] [Rafael Holdings to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference](https://www.quantisnow.com/insight/rafael-holdings-to-participate-in-the-guggenheim-3rd-annual-healthcare-6769024)
- 2026-10-29 15:35 UTC [SEC Form 10-K] [SEC Form 10-K filed by Rafael Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-rafael-holdings-inc-6763083)
- 2026-10-29 12:16 UTC [SEC Form 8-K] [SEC Form 8-K filed by Rafael Holdings Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-rafael-holdings-inc-6762731)
- 2026-10-29 12:00 UTC [Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results and Provides Corporate Update](https://www.quantisnow.com/insight/rafael-holdings-reports-fourth-quarter-and-full-year-fiscal-2026-6762590)
- 2026-10-29 11:00 UTC [Rafael Holdings Announces Submission of New Drug Application to FDA for Trappsol® Cyclo™ (remibetadex) for the Treatment of Niemann-Pick Disease Type C](https://www.quantisnow.com/insight/rafael-holdings-announces-submission-of-new-drug-application-to-fda-6762306)
- 2026-10-27 20:50 UTC [SEC Form 4] [SEC Form 4 filed by Rafael Holdings Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-rafael-holdings-inc-6759602)
- 2026-09-30 11:23 UTC [SEC Form 8-K] [Rafael Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/rafael-holdings-inc-filed-sec-form-8-k-regulation-fd-disclosure-6729907)
- 2026-09-30 11:00 UTC [Earnings Date] [Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)](https://www.quantisnow.com/insight/rafael-holdings-announces-topline-results-from-the-pivotal-phase-3-6729869)
- 2026-09-23 18:36 UTC [SEC Form 4] [Chief Financial Officer Polinsky David covered exercise/tax liability with 2,027 units of Class B Common Stock, decreasing direct ownership by 0.68% to 297,084 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-polinsky-david-covered-exercisetax-liability-with-2027-6724045)
- 2026-08-10 13:01 UTC [Leadership Update] [Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage](https://www.quantisnow.com/insight/ernexa-therapeutics-strengthens-board-with-veteran-biotech-executive-david-polinsky-6673059)
- 2026-07-31 20:54 UTC [SEC Form 4] [Exec Chairman, CEO & President Jonas Howard S was granted 54,945 units of Class B Common Stock, increasing direct ownership by 12% to 512,030 units (SEC Form 4)](https://www.quantisnow.com/insight/exec-chairman-ceo-president-jonas-howard-s-was-granted-54945-6658135)
- 2026-07-08 20:45 UTC [SEC Form 8-K] [Rafael Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/rafael-holdings-inc-filed-sec-form-8-k-regulation-fd-disclosure-6631773)
- 2026-06-23 19:32 UTC [SEC Form 4] [Chief Financial Officer Polinsky David covered exercise/tax liability with 2,386 units of Class B Common Stock, decreasing direct ownership by 0.79% to 299,111 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-polinsky-david-covered-exercisetax-liability-with-2386-6612358)
- 2026-06-16 19:55 UTC [SEC Form 4] [Exec Chairman, CEO & President Jonas Howard S was granted 142,857 units of Class B Common Stock and covered exercise/tax liability with 8,786 units of Class B Common Stock, increasing direct ownership by 42% to 457,085 units (SEC Form 4)](https://www.quantisnow.com/insight/exec-chairman-ceo-president-jonas-howard-s-was-granted-142857-6604540)
- 2026-06-11 12:17 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Rafael Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-rafael-holdings-inc-6598319)
- 2026-06-11 11:55 UTC [SEC Form 8-K] [Rafael Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/rafael-holdings-inc-filed-sec-form-8-k-results-of-operations-6598190)
- 2026-06-11 11:30 UTC [Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results](https://www.quantisnow.com/insight/rafael-holdings-reports-third-quarter-fiscal-2026-financial-results-6598172)
- 2026-06-10 11:49 UTC [SEC Form 8-K] [Rafael Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/rafael-holdings-inc-filed-sec-form-8-k-regulation-fd-disclosure-6596386)
- 2026-06-10 11:30 UTC [Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C](https://www.quantisnow.com/insight/rafael-holdings-announces-completion-of-last-patient-last-visit-for-6596356)
- 2026-04-22 11:21 UTC [SEC Form 8-K] [Rafael Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/rafael-holdings-inc-filed-sec-form-8-k-regulation-fd-disclosure-6509393)
- 2026-04-22 11:00 UTC [Rafael Holdings Announces Patent Licensing Agreement with MIT for "Small Molecules to Improve Myelination in ApoE4 positive Alzheimer's Disease"](https://www.quantisnow.com/insight/rafael-holdings-announces-patent-licensing-agreement-with-mit-for-small-6509322)
- 2026-03-24 16:24 UTC [SEC Form 4] [SEC Form 4 filed by Polinsky David](https://www.quantisnow.com/insight/sec-form-4-filed-by-polinsky-david-6466645)
- 2026-03-17 16:48 UTC [SEC Form 4] [Exec Chairman, CEO & President Jonas Howard S covered exercise/tax liability with 9,826 units of Class B Common Stock, decreasing direct ownership by 3% to 323,014 units (SEC Form 4)](https://www.quantisnow.com/insight/exec-chairman-ceo-president-jonas-howard-s-covered-exercisetax-liability-6451831)
- 2026-03-16 20:40 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Rafael Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-rafael-holdings-inc-6449904)
- 2026-03-16 20:18 UTC [SEC Form 8-K] [Rafael Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/rafael-holdings-inc-filed-sec-form-8-k-results-of-operations-6449569)
- 2026-03-16 20:01 UTC [Rafael Holdings Reports Second Quarter Fiscal 2026 Financial Results](https://www.quantisnow.com/insight/rafael-holdings-reports-second-quarter-fiscal-2026-financial-results-6449175)
- 2026-01-30 21:01 UTC [SEC Form 4] [Director Sieger Markus was granted 29,528 units of Class B Common Stock, increasing direct ownership by 16% to 219,710 units (SEC Form 4)](https://www.quantisnow.com/insight/director-sieger-markus-was-granted-29528-units-of-class-b-6367863)
- 2026-01-29 18:24 UTC [SEC Form 4] [Director Weiss Michael J was granted 39,370 units of Class B Common Stock, increasing direct ownership by 38% to 141,861 units (SEC Form 4)](https://www.quantisnow.com/insight/director-weiss-michael-j-was-granted-39370-units-of-class-6365704)
- 2026-01-29 18:23 UTC [SEC Form 4] [Director Stein Mark N was granted 39,370 units of Class B Common Stock, increasing direct ownership by 343% to 50,845 units (SEC Form 4)](https://www.quantisnow.com/insight/director-stein-mark-n-was-granted-39370-units-of-class-6365703)
- 2026-01-29 18:23 UTC [SEC Form 4] [Director Grayson Alan was granted 6,562 units of Class B Common Stock (SEC Form 4)](https://www.quantisnow.com/insight/director-grayson-alan-was-granted-6562-units-of-class-b-6365702)
- 2026-01-27 21:38 UTC [SEC Form S-8] [SEC Form S-8 filed by Rafael Holdings Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-rafael-holdings-inc-6362547)
- 2026-01-15 21:22 UTC [SEC Form 4] [Exec Chairman, CEO & President Jonas Howard S was granted 75,000 units of Class B Common Stock, increasing direct ownership by 29% to 332,840 units (SEC Form 4)](https://www.quantisnow.com/insight/exec-chairman-ceo-president-jonas-howard-s-was-granted-75000-6350946)
- 2026-01-15 21:22 UTC [SEC Form 4] [Chief Financial Officer Polinsky David covered exercise/tax liability with 4,865 units of Class B Common Stock and was granted 50,000 units of Class B Common Stock, increasing direct ownership by 17% to 303,815 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-polinsky-david-covered-exercisetax-liability-with-4865-6350942)
- 2026-01-12 21:29 UTC [SEC Form 8-K] [Rafael Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/rafael-holdings-inc-filed-sec-form-8-k-submission-of-matters-6346570)
- 2025-12-23 20:01 UTC [SEC Form 4] [Chief Financial Officer Polinsky David covered exercise/tax liability with 1,961 units of Class B Common Stock, decreasing direct ownership by 0.75% to 258,680 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-polinsky-david-covered-exercisetax-liability-with-1961-6326578)
- 2025-12-16 23:56 UTC [SEC Form 4] [Exec Chairman, CEO & President Jonas Howard S covered exercise/tax liability with 9,867 units of Class B Common Stock, decreasing direct ownership by 4% to 257,840 units (SEC Form 4)](https://www.quantisnow.com/insight/exec-chairman-ceo-president-jonas-howard-s-covered-exercisetax-liability-6318733)
- 2025-12-12 02:46 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Rafael Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-rafael-holdings-inc-6313264)
- 2025-12-11 21:19 UTC [SEC Form 8-K] [Rafael Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/rafael-holdings-inc-filed-sec-form-8-k-results-of-operations-6312561)
- 2025-12-11 21:01 UTC [Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results](https://www.quantisnow.com/insight/rafael-holdings-reports-first-quarter-fiscal-2026-financial-results-6312314)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/RFL
- Earnings history: https://www.quantisnow.com/earnings/RFL
- Dividend history: https://www.quantisnow.com/dividends/RFL
- Insider transactions: https://www.quantisnow.com/insiders/RFL
- Options chain: https://www.quantisnow.com/options/RFL
- SEC 8-K filings only: https://www.quantisnow.com/company/RFL/8-k
- RSS and alerts for RFL: https://www.quantisnow.com/docs/rss-feeds.md